| Sep 16 |
Korro Bio Announces Collaboration with Novo Nordisk to Develop Two Therapeutic Candidates
|
| Sep 4 |
Will Korro Bio (NASDAQ:KRRO) Spend Its Cash Wisely?
|
| Aug 28 |
Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors
|
| Aug 27 |
Korro to Participate in Upcoming September Investor and Scientific Conferences
|
| Aug 14 |
Korro Bio GAAP EPS of -$2.43 beats by $0.29
|
| Aug 13 |
Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates
|
| Jul 3 |
Korro Bio: Interesting RNA Biotech With 2nd Half 2025 Interim Data
|
| Jul 1 |
Korro Bio joins Russell 2000, Russell 3000, Russell Microcap indexes
|
| Jul 1 |
Korro Joins the Russell 2000®, Russell 3000®, and Russell Microcap® Indexes
|
| May 30 |
Korro to Participate in Upcoming June Investor and Scientific Conferences
|
